Heritage study suggests ER visits from abortion pills rose after FDA lifted in-person requirement By Valerie Richardson - The Washington Times Shares
Supreme Court dismisses challenge to abortion pill, says pro-life doctors lack standing By Alex Swoyer and Stephen Dinan - The Washington Times Shares
Mail-order abortion scheme prioritizes politics, not health care By Emily Erin Davis – Special to Higher Ground Shares
New fight for life: Chemical abortion access threatens vulnerable women By S. Ernie Walton – Special to Higher Ground Shares
U.S. seizes more illegal e-cigarettes, but new ones are launching By Matthew Perrone - Associated Press Shares
Justice Department to take abortion pill fight to Supreme Court By Alex Swoyer - The Washington Times Shares
Abortion issue returns to Supreme Court as DOJ fights ruling on FDA’s pill approval By Alex Swoyer and Valerie Richardson - The Washington Times Shares
Juul settlement will cost e-cigarette producer nearly $440 million, ban youth marketing By Brad Matthews - The Washington Times Shares
The FDA’s mass murder of more than half a million Americans By Peter Navarro and Dr. Steven Hatfill Shares
FDA still skeptical of ALS drug ahead of high-stakes meeting By Matthew Perrone - Associated Press Shares
Operation Fly Formula flops as White House intervention fails to fill store shelves By Susan Ferrechio and Tom Howell Jr. - The Washington Times Shares
Promising therapies for terminal patients advance while approval remains stagnant By U.S. Sen. Mike Braun Shares